UBE2V2

Across TCGA pan-cancer cohorts, UBE2V2 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of UBE2V2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where UBE2V2 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types UBE2V2 is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.

COAD, CCRCC, and PDAC are the cancer types where UBE2V2 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2V2 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	−0.616	<.001	11	view →
CCRCC	Male	All	+0.151	<.001	10	view →
PDAC	Male	All	+0.832	<.001	8	view →
HNSC	All	III,IV	+0.167	<.001	8	view →
LUAD	All	All	−0.102	<.001	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

UBE2V2–COAD

Open the COAD breakdown →